Meinian Onehealth announced that it expects operating revenue from January 1, 2025, to June 30, 2025, to be between 3.96 billion yuan and 4.2 billion yuan, a decrease of 0.12% to 5.83% compared to the same period last year. It is expected that the net profit attributable to shareholders of the listed company will be a loss of 192 million yuan to 236 million yuan, compared to a loss of 216 million yuan in the same period last year. The net profit after deducting non-recurring gains and losses is expected to be a loss of 205 million yuan to 253 million yuan, compared to a loss of 225 million yuan in the same period last year. The basic earnings per share are expected to be a loss of 0.05 yuan to 0.06 yuan per share, compared to a loss of 0.06 yuan per share in the same period last year